Virology
TWiV 154: Symbiotic safecrackers
By Vincent Racaniello
Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Vincent, Alan, and Rich are very enthusiastic about two studies that show how gut bacteria help viral invaders. [powerpress url="http://traffic.libsyn.com/twiv/TWiV154.mp3"] Click the arrow above to play, or right-click to download TWiV 154 (46 MB .mp3, 77 minutes). Subscribe to TWiV (free) in iTunes ...
TWiP 31: A malaria vaccine
By Vincent Racaniello
Hosts: Vincent Racaniello and Dickson Despommier Vincent and Dickson discuss the promising results of a phase III trial of a malaria vaccine in African children. [powerpress url="http://traffic.libsyn.com/twip/TWiP031.mp3"] Click the arrow above to play, or right-click to download TWiP #31 (50 MB .mp3, 70 minutes). Links for this episode: First results of RTS,S/AS01 ...
TWiM #18: Escherichia coli K-12, an emerging pathogen?
By Vincent Racaniello
Hosts: Vincent Racaniello, Michael Schmidt, Stanley Maloy and Elio Schaechter. On episode #18 of the podcast This Week in Microbiology, Vincent, Michael, Elio, and Stanley explain how to make the human intestinal commensal and benign laboratory bacterium Escherichia coli K-12 into an invasive organism, and the unearthing of century-old spores in New York City. ...
TWiV 153: Rabid reindeer and protective prions
By Vincent Racaniello
Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Vincent, Alan, and Rich review an outbreak of rabies in arctic foxes and reindeer in Norway, and a prion that makes you go antiviral. [powerpress url="http://traffic.libsyn.com/twiv/TWiV153.mp3"] Click the arrow above to play, or right-click to download TWiV 153 (55 MB .mp3, 92 minutes). ...
Results of the Blood XMRV Scientific Research Working Group
By Vincent Racaniello
The Blood XMRV Scientific Research Working Group was formed to design and carry out a study to determine whether xenotropic murine leukemia virus-related virus (XMRV) posed a threat to blood safety. Phase III results were published on Sept. 22, 2011 in Science. In an upcoming webinar study leaders Graham Simmons ...
